Placebo yoghurt
Dietary Supplement100g of placebo yoghurt will be taken at 10:00 am and 4:00 pm, respectively; 2 times per day.
NCT Number: NCT01682798
The purpose of this study is to determine whether Yili "Chang Qing" Pro-ABB yoghurt is effective in improving mild constipation and the intestinal micro-ecology environment & alimentation.
Looking for future studies?
Notify Me25 year–45 year
All sexes
Interventional
Not applicable
NanMoFang Community Health Service Center, ChaoYang District, Beijing Municipality, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
100g of placebo yoghurt will be taken at 10:00 am and 4:00 pm, respectively; 2 times per day.
100g of Yili "Chang Qing" Pro-ABB yoghurt will be taken by at 10:00 am and 4:00 pm, respectively; 2 times per day.
Other names: 100g of Yili "Chang Qing" Pro-ABB yoghurt will be taken by at 10:00 am and 4:00 pm, respectively; 2 times per day.
Time frame: Baseline & 3 weeks
Time frame: Baseline & 3 Weeks
Inner Mongolia Yili Industrial Group Co., Ltd
Industry
The Clinical Research on the Efficiency of Yili "Changqing" Pro-ABB Probiotic Yogurt in the Improvement of Human Gastrointestinal Tract System
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01677715
Abdominal Pain, Common Cold
ChaoYang District, Beijing Municipality, China
View Trial DetailsNCT01837940
Abdominal Pain, Constipation
Örebro, Närke, Sweden
View Trial DetailsNCT06755671
Abdominal Pain, Anorexia
Hangzhou, Zhejiang, China
View Trial DetailsNCT05247333
Acne, Acne Vulgaris
Madrid, Spain
View Trial Details